Summary of project PR001022

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench,, where it has been assigned Project ID PR001022. The data can be accessed directly via it's Project DOI: 10.21228/M8KT26 This work is supported by NIH grant, U2C- DK119886.


Project ID: PR001022
Project DOI:doi: 10.21228/M8KT26
Project Title:Effects of glucagon infusion on plasma metabolome in individuals with overweight/obesity
Project Summary:Objective: We sought to identify the circulating metabolites that would serve as markers of glucagon action. Design: In this study, we performed a continuous 72-hour glucagon infusion in healthy individuals with overweight/obesity. Participants were randomized to either glucagon (12.5 ng/kg/min) (GCG 12.5) or glucagon (25 ng/kg/min) GCG 25 or a placebo control were included. A comprehensive metabolomics analysis was then performed from plasma isolated at several time points during the infusion to identify markers of glucagon activity.
Institute:Translational Research Institute- AdventHealth Orlando
Last Name:Whytock
First Name:Katie
Address:301 E Princeton St, FL, USA, 32804
Funding Source:Sanofi

Summary of all studies in project PR001022

Study IDStudy TitleSpeciesInstituteAnalysis
(* : Contains Untargted data)
(* : Contains raw data)
ST001515 A Metabolomic Signature of Glucagon Action in Healthy Individuals with Overweight/Obesity Humans Homo sapiens Translational Research Institute- AdventHealth Orlando MS 2020-12-01 1 187 Not available